Skip to main content
Premium Trial:

Request an Annual Quote

Innovate UK Grants University of Oxford, ATDBio £370K for Single-Cell Sequencing Tech Development

NEW YORK – Synthetic oligonucleotide manufacturer ATDBio and researchers from the University of Oxford have won a £369,632 ($480,084) grant from Innovate UK to develop tagged microbeads for use in single-cell RNA sequencing library preparation.

ATDBio will develop improved oligonucleotide tagged beads, "which will help enhance the quality of the sequencing results and enable new types of experiments," the UK firm said in a statement on Tuesday.

Researchers led by Udo Oppermann, director of laboratory sciences at Oxford's Botnar Research Centre, will assess bead performance and investigate additional uses for them outside of single-cell RNA-seq.

"Our collaboration with the University of Oxford began in response to frequent comments from our customers about the need for improved droplet-based scRNA-seq microbeads," ATDBio CSO Tom Brown said in a statement. "This grant from Innovate UK allows ATDBio to use its oligonucleotide synthesis expertise to make the technology more effective and more accessible to researchers and clinicians."

ATDBio has laboratories in Southampton and Oxford.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.